Filter
381
Text search:
virus
variants
Featured
Recommendations
69
New Publications
26
Language
Document type
Guidelines
115
Studies & Reports
80
No document type
59
Fact sheets
46
Strategic & Response Plan
31
Manuals
23
Training Material
8
Videos
8
Resource Platforms
5
Situation Updates
3
Brochures
2
Infographics
1
Countries / Regions
Global
23
Latin America and the Carribbean
16
Africa
13
India
9
Western and Central Europe
8
Germany
7
Kenya
7
Brazil
7
South Africa
5
East and Southern Africa
5
West and Central Africa
5
Nigeria
4
Niger
4
Malawi
4
Middle East and North Africa
4
Russia
4
Senegal
3
Congo, Democratic Republic of
3
Ethiopia
3
Cameroon
3
South Sudan
3
South–East Asia Region
3
Eastern Europe
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Haiti
2
Lebanon
2
Turkey
2
Syria
2
Chad
2
Rwanda
2
Mozambique
2
Sudan
2
Peru
2
Bolivia
2
Chile
2
Asia
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Ghana
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Egypt
1
Mauritania
1
Benin
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Gabon
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
95
Clinical Guidelines
31
Public Health
16
Key Resources
14
Pharmacy & Technologies
12
Women & Child Health
7
Capacity Building
3
Toolboxes
COVID-19
218
HIV
22
Rapid Response
19
Planetary Health
11
NTDs
11
2.0 Rapid Response
9
TB
8
Ebola & Marburg
7
Health Financing Toolbox
7
AMR
6
Global Health Education
5
Mental Health
4
NCDs
4
Malaria
4
Caregiver
3
Refugee
2
Pharmacy
2
Cholera
1
Polio
1
Conflict
1
Zika
1
Specific Hazards
1
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
What are the variants circulating at this time? How are variants classified as variants of interest or concern? What does this mean for the public?
...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The
...
The NY Times variant tracker is perhaps the most accessible and relevant publication for non-molecular biologists and the general public
Each coronavirus contains nearly 30,000 letters of RNA. This genetic information allows the virus to infect ce
...
The New England Journal of Medicine
Genetic analysis of the virus indicates that it is closely related (97% identical) to variants of Ebola virus
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se répl
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun
...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les poi
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
Countries across the world are facing diverse epidemiological situations with varying response
capacities and access to life saving tools. The World Health Organization (WHO) recommends that national authorities continue to apply a risk-based approach when implementing measures related to COVID-19
...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t
...
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2
...
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and
...
Weekly epidemiological update on COVID-19, 28 September 2022
21 Dec 2021. Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants
26 March 2021
If you have already had COVID-19 do you still need both doses of the vaccine? Do these vaccines protect you against infection? Do they protect us against variants? WHO’s Dr Katherine O’Brien answers these questions in Science in 5
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other
...
